Published in J Allergy Clin Immunol on September 26, 2008
Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med (2010) 2.61
Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. Nature (2016) 2.43
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol (2011) 1.46
Rheumatologic manifestations of primary immunodeficiency diseases. Clin Rheumatol (2016) 1.42
NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis. Blood (2015) 1.41
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A (2011) 1.30
Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci U S A (2011) 1.29
CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. J Clin Invest (2012) 1.07
Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One (2011) 1.07
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol (2010) 1.01
Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid Redox Signal (2014) 0.94
Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis. Blood (2015) 0.93
Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease. Clin Exp Immunol (2011) 0.92
An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD. Blood (2013) 0.92
Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function. PLoS One (2014) 0.89
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease. J Clin Immunol (2013) 0.87
Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. PLoS One (2014) 0.86
Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome. J Inflamm (Lond) (2010) 0.85
A role for NADPH oxidase in antigen presentation. Front Immunol (2013) 0.83
Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN. J Am Soc Nephrol (2014) 0.82
Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease. J Clin Immunol (2013) 0.82
Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep (2013) 0.81
Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells. J Immunol (2012) 0.81
New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81
Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils. Clin Sci (Lond) (2015) 0.78
B-cell activating factor (BAFF) is elevated in chronic granulomatous disease. Clin Immunol (2013) 0.77
Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature. BMC Res Notes (2010) 0.77
Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 Diabetes. Diabetes (2015) 0.76
Systemic lupus erythematosus-associated neutrophil cytosolic factor 2 mutation affects the structure of NADPH oxidase complex. J Biol Chem (2015) 0.76
Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation. Cell Death Dis (2016) 0.75
Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. J Allergy Clin Immunol Pract (2016) 0.75
Redox Regulation of Pro-IL-1β Processing May Contribute to the Increased Severity of Serum-Induced Arthritis in NOX2-Deficient Mice. Antioxid Redox Signal (2015) 0.75
Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease. J Am Acad Dermatol (2014) 0.75
Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide. Oxid Med Cell Longev (2017) 0.75
Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS. PLoS One (2014) 0.75
Presence of a Juvenile Idiopathic Arthritis and Chronic Granulomatous Disease in a Child. Iran J Pediatr (2015) 0.75
Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD. J Clin Immunol (2015) 0.75
Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease. J Clin Immunol (2014) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet (1995) 7.34
Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) (2000) 4.45
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature (2008) 4.28
The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med (1995) 4.25
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol (2004) 2.96
Gastrointestinal involvement in chronic granulomatous disease. Pediatrics (2004) 2.80
Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol (2003) 1.53
Immune deficiency and autoimmunity. Autoimmun Rev (2003) 1.27
Juvenile idiopathic arthritis. Autoimmun Rev (2005) 1.18
Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol (2007) 1.12
Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum (1994) 1.10
Sarcoidosis in chronic granulomatous disease. Pediatrics (2006) 1.04
Venous thromboembolism: pathophysiology, clinical features, and prevention. BMJ (2002) 1.03
Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum (1991) 1.02
Recurrent eosinophilic cystitis in a child with chronic granulomatous disease. J Pediatr Hematol Oncol (2004) 1.00
Large pericardial effusions of inflammatory origin in childhood. Cardiol Young (2003) 1.00
Discoid lupus erythematosus-like skin changes in patients with autosomal recessive chronic granulomatous disease. Arch Dermatol (1990) 0.90
Histology and immunohistology of IgA nephropathy. J Nephrol (2005) 0.89
Phagocytic activity of polymorphonuclear leucocytes in patients with IgA nephropathy. Clin Nephrol (1983) 0.88
Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus. Nephrol Dial Transplant (1995) 0.85
Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease. J Eur Acad Dermatol Venereol (2000) 0.85
Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease. Ann Hematol (2005) 0.84
Celiac disease and pulmonary hemosiderosis in a patient with chronic granulomatous disease. Pediatr Pulmonol (2004) 0.84
Discoid lupus erythematosus and X-linked chronic granulomatous disease. Pediatr Dermatol (1986) 0.84
Granulomatous inflammation of the heart. Heart Vessels Suppl (1985) 0.81
Pericardial effusions in two boys with chronic granulomatous disease. Pediatr Radiol (1999) 0.80
Concept of autoimmune disease. Ann N Y Acad Sci (1966) 0.80
IgA nephropathy in a patient with chronic granulomatous disease. J Nephrol (2002) 0.79
A female case of chronic granulomatous disease (CGD) associated with chronic idiopathic thrombocytopenic purpura. Hiroshima J Med Sci (1980) 0.78
[Constrictive pericarditis as a complication of chronic granulomatous disease of childhood]. Rev Hosp Clin Fac Med Sao Paulo (1988) 0.78
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
A diversity profile of the human skin microbiota. Genome Res (2008) 7.65
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17
Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med (2008) 5.34
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell (2002) 5.10
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum (2002) 4.98
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52
Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med (2003) 4.46
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res (2012) 3.71
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet (2005) 3.26
Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood (2011) 3.21
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood (2009) 3.00
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet (2003) 2.88
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2013) 2.82
Gastrointestinal involvement in chronic granulomatous disease. Pediatrics (2004) 2.80
Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med (2010) 2.61
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) (2002) 2.51
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum (2005) 2.20
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum (2003) 2.11
Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol (2007) 2.05
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion (2003) 2.05
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol (2009) 2.03
Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum (2009) 2.02
Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol (2007) 1.89
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum (2010) 1.86
Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int (2008) 1.86
WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol (2009) 1.85
Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood (2011) 1.83
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med (2003) 1.83
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity (2008) 1.83
Defining early mycosis fungoides. J Am Acad Dermatol (2005) 1.78
Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) (2008) 1.74
Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood (2009) 1.73
Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis (2010) 1.70
Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell (2007) 1.69
Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol (2004) 1.67
An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol (2003) 1.66
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood (2014) 1.66
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood (2011) 1.65
Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol (2004) 1.63
Nocardia infection in chronic granulomatous disease. Clin Infect Dis (2002) 1.62
miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol (2013) 1.57
Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J Infect Dis (2003) 1.56
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant (2011) 1.54
Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol (2004) 1.53
Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis (2007) 1.52
Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency. J Immunol (2009) 1.52
Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis (2004) 1.50
Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood (2010) 1.47
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol (2011) 1.46
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res (2009) 1.46
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity. Arch Dermatol (2010) 1.43
Role of laeA in the Regulation of alb1, gliP, Conidial Morphology, and Virulence in Aspergillus fumigatus. Eukaryot Cell (2007) 1.41
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis (2011) 1.39
NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol (2003) 1.38
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood (2009) 1.38
Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol (2002) 1.37
Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One (2008) 1.34
Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol (2005) 1.34
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.33
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Blood (2010) 1.33
Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol (2002) 1.33
Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics (2010) 1.30
CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells (2004) 1.29
Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome. Exp Hematol (2005) 1.28
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood (2008) 1.28
Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease. Emerg Infect Dis (2010) 1.27
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum (2004) 1.25
Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis (2010) 1.25